TOFACITINIB 11 mg/1
TOFACITINIB · TABLET, EXTENDED RELEASE · Aurobindo Pharma Limited
No Recall History
Plain English
TOFACITINIB is a tablet, extended release containing tofacitinib at 11 mg/1, taken oral. Manufactured by Aurobindo Pharma Limited.
Key Facts
- Brand Name
- TOFACITINIB
- Generic Name
- TOFACITINIB
- NDC Code (Product)
59651-685- Manufacturer
- Aurobindo Pharma Limited
- Strength
- 11 mg/1
- Dosage Form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing Status
- Application #
- ANDA218462
- Marketing Start
- 05/14/2026
Recall History
No Recall HistoryFrequently Asked Questions
What is TOFACITINIB used for?
TOFACITINIB contains TOFACITINIB. It is a tablet, extended release taken oral. Consult your doctor for specific uses.
Is TOFACITINIB a controlled substance?
TOFACITINIB is not classified as a controlled substance by the DEA.
What is the generic name for TOFACITINIB?
The generic name for TOFACITINIB is TOFACITINIB. There are 11 other brand versions of TOFACITINIB.
What is the NDC code for TOFACITINIB 11 mg/1?
The NDC (National Drug Code) for TOFACITINIB 11 mg/1 is 59651-685, listed by Aurobindo Pharma Limited.